Minimal residual disease at the time of peripheral blood stem cell harvest in patients with advanced neuroblastoma. [electronic resource]
Producer: 20010816Description: 213-9 p. digitalISSN:- 0098-1532
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- genetics
- Child
- Child, Preschool
- Combined Modality Therapy
- Hematopoietic Stem Cell Mobilization
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Infant
- Life Tables
- Neoplasm Proteins -- genetics
- Neoplasm, Residual
- Neoplastic Cells, Circulating
- Neuroblastoma -- blood
- RNA, Messenger -- blood
- RNA, Neoplasm -- blood
- Remission Induction
- Reverse Transcriptase Polymerase Chain Reaction
- Sensitivity and Specificity
- Survival Analysis
- Transplantation, Autologous -- adverse effects
- Treatment Outcome
- Tumor Cells, Cultured -- chemistry
- Tyrosine 3-Monooxygenase -- genetics
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.